Novel heparin/heparan sulfate mimics as inhibitors of HGF/SF-induced MET activation.
The synthesis of simple, non-sugar glycosaminoglycan (GAG) mimics has been achieved and the analogues evaluated for their ability to inhibit the activation of the MET receptor by hepatocyte growth factor/scatter factor (HGF/SF).